ScholarIQanswers from OpenAlex

<scp>ALT</scp> flares during nucleotide analogue therapy are associated with <scp>HB</scp>sAg loss in genotype A <scp>HB</scp>eAg‐positive chronic hepatitis B

PaperCitations, authors & open-access status

<scp>ALT</scp> flares during nucleotide analogue therapy are associated with <scp>HB</scp>sAg loss in genotype A <scp>HB</scp>eAg‐positive chronic hepatitis B is a paper indexed in ScholarIQ from OpenAlex.

How many citations does <scp>ALT</scp> flares during nucleotide analogue therapy are associated with <scp>HB</scp>sAg loss in genotype A <scp>HB</scp>eAg‐positive chronic hepatitis B have?

ScholarIQcitation count

<scp>ALT</scp> flares during nucleotide analogue therapy are associated with <scp>HB</scp>sAg loss in genotype A <scp>HB</scp>eAg‐positive chronic hepatitis B has 36 citations in the OpenAlex counts ScholarIQ stores.

When was <scp>ALT</scp> flares during nucleotide analogue therapy are associated with <scp>HB</scp>sAg loss in genotype A <scp>HB</scp>eAg‐positive chronic hepatitis B published?

ScholarIQyear

<scp>ALT</scp> flares during nucleotide analogue therapy are associated with <scp>HB</scp>sAg loss in genotype A <scp>HB</scp>eAg‐positive chronic hepatitis B has 2018 year in the ScholarIQ index.

What is the open-access status of <scp>ALT</scp> flares during nucleotide analogue therapy are associated with <scp>HB</scp>sAg loss in genotype A <scp>HB</scp>eAg‐positive chronic hepatitis B?

ScholarIQoa status

<scp>ALT</scp> flares during nucleotide analogue therapy are associated with <scp>HB</scp>sAg loss in genotype A <scp>HB</scp>eAg‐positive chronic hepatitis B has green oa status in the ScholarIQ index.

What is the DOI of <scp>ALT</scp> flares during nucleotide analogue therapy are associated with <scp>HB</scp>sAg loss in genotype A <scp>HB</scp>eAg‐positive chronic hepatitis B?

ScholarIQdoi

The DOI for <scp>ALT</scp> flares during nucleotide analogue therapy are associated with <scp>HB</scp>sAg loss in genotype A <scp>HB</scp>eAg‐positive chronic hepatitis B is on the source record.

What is the PMID of <scp>ALT</scp> flares during nucleotide analogue therapy are associated with <scp>HB</scp>sAg loss in genotype A <scp>HB</scp>eAg‐positive chronic hepatitis B?

ScholarIQpmid

The PMID for <scp>ALT</scp> flares during nucleotide analogue therapy are associated with <scp>HB</scp>sAg loss in genotype A <scp>HB</scp>eAg‐positive chronic hepatitis B is on the source record.

What is the OpenAlex record for <scp>ALT</scp> flares during nucleotide analogue therapy are associated with <scp>HB</scp>sAg loss in genotype A <scp>HB</scp>eAg‐positive chronic hepatitis B?

ScholarIQopenalex

The OpenAlex for <scp>ALT</scp> flares during nucleotide analogue therapy are associated with <scp>HB</scp>sAg loss in genotype A <scp>HB</scp>eAg‐positive chronic hepatitis B is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial